Post-transplant early recurrent proteinuria in patients with focal glomerulosclerosis-Angiotensin II immunostaining and treatment outcome

Clinical Transplantation, Supplement

Volumn 19, Issue 14, 2005, Pages 12-19

  Mizuiri, Sonoo ^a   Kawamura, Takeshi ^a   Miyagi, Moriatsu ^a   Arai, Kenji ^a   Sakai, Ken ^a   Aikawa, Atsushi ^a   Ohara, Takehiro ^a   Shibuya, Kazutoshi ^a   Ishikawa, Yukio ^a   Kawamura, Sadao ^a   Hasegawa, Akira ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II; Focal segmental glomerulosclerosis; Renal transplantation

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LYMPHOCYTE ANTIBODY; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADOLESCENT; ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; MALE; MICROSCOPY; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; RENAL GRAFT DYSFUNCTION; REVIEW; SCHOOL CHILD; TREATMENT OUTCOME;

EID: 22244471071     PISSN: 13996738     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00399.x     Document Type: Review

References (19)

1. Artero M, Biava C, Amend W. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 1992: 92: 375.
2. Deegens JK, Andersdottir MB, Croockewit S et al. Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplantation. Transpl Int 2004: 17: 151.
3. Newstead CG. Recurrent disease in renal transplants. Nephrol Dial Transplant 2003: 18S6: vi68.
4. Andersdottir MB, Ajubi N, Croockewit S et al. Recurrent focal glomerulosclerosis: natural course and treatment with plasma exchange. Nephrol Dial Transplant 1999: 14: 2650.
5. Hoffmann S, Podlich D, Hähnel B et al. Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 2004: 15: 1475.
6. Mizuiri S, Yoshikawa H, Tanegashima M et al. Renal ACE immunohistochemical localization in NIDDM patients with nephropathy. Am J Kidney Dis 1998: 31: 301.
7. Braam B, Mitchell KD, Fox J et al. Proximal tubular secretion of angiotensin II in rats. Am J Physiol 1993: 264: F891.
8. Loghmann-Adham M, Soto CE, Inagami T et al. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Am J Physiol Renal 2004: 287: F775.
9. Graciano ML, Cavaglieri RDC, Dellê H. Intrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 2004: 15: 1805.
10. I receptor in remnant kidney: strong renoprotection by therapy with losartan and nonsteroidal anti-inflammatory. Am J Physiol 2004: 286: F945.
11. Mezzano SA, Aros CA, Droguett A et al. Renin angiotensin II up-regulation and myofibroblast activation in human membranous nephropathy. Kidney Int 2003: 64S86: S39.
12. Mezzano SA, Droguett A, Burgos E. Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int 2003: 64S86: S64.
13. Geleilete TJ, Melo GC, Costa RS. Role of myofibroblasts, macrophages, transforming growth factor-β endothelin, angiotensin II, and fibronectin in the progression of tubulointerstitial nephritis induced by gentamicin. J Nephrol 2002: 15: 633.
14. Rizkalla B, Forbes JM, Cao Z et al. Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes. Role of the renin-angiotensin system. J Hypertens 2005: 23: 153.
15. Campbell RC. The renin-angiotensin system; a 21st century perspective. J Am Soc Nephrol 2004: 15: 1963.
16. Harrison-Bernard LM, Navar LG, Ho MM et al. Immunohistochemical localization of ang II AT1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol 1997: 273: F170.
17. Lassila M, Cooper ME, Jandeleit-Dahm K. Antiproteinuric effect of RAS blockade: new mechanisms. Curr Hypertens Rep 2004: 6: 383.
18. Cochat P, Schell M, Ranchin B et al. Management of recent nephrotic syndrome after kidney transplantation in children. Clin Nephrol 1996: 46: 17.
19. Odoricio JS, Knechtle SJ, Rayhill SC. The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Transplantation 1996: 61: 228.